Redefining the Prognostic Significance of t(11;14) Multiple Myeloma

被引：2
|
作者：
Bal, Susan
Giri, Smith
Godby, Kelly N.
Costa, Luciano J.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Impact of t(11;14) in Multiple Myeloma on Response to Treatment and Survival
    Puertas, Borja
    Sobejano, Eduardo
    Gomez, Sandra
    Hernandez, Alberto
    Alejo, Elena
    Alonso, David
    Maria Navarro, Jose
    Puerta, Carlos
    Garcia, Pablo
    Zapata, Evelyn
    Redondo, Elena
    Rey, Beatriz
    Gutierrez, Norma
    Puig, Noemi
    Garcia-Sanz, Ramon
    Victoria Mateos, Maria
    Escalante, Fernando
    Gonzalez-Calle, Veronica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S413 - S414
  • [22] Multiple myeloma with t(11;14): impact of novel agents on outcome
    Puertas, Borja
    Gonzalez-Calle, Veronica
    Sobejano-Fuertes, Eduardo
    Escalante, Fernando
    Rey-Bua, Beatriz
    Padilla, Irene
    Garcia-Sanz, Ramon
    Puig, Noemi
    Gutierrez, Norma C. C.
    Mateos, Maria-Victoria
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [23] Translocation t(4; 14) and multiple myeloma : is it a new independent prognostic factor?
    Manier, Salomon
    Leleu, Xavier
    HEMATOLOGIE, 2011, 17 (01): : 17 - 17
  • [24] Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
    Avet-Loiseau, Herve
    Malard, Florent
    Campion, Loic
    Magrangeas, Florence
    Sebban, Catherine
    Lioure, Bruno
    Decaux, Olivier
    Lamy, Thierry
    Legros, Laurence
    Fuzibet, Jean-Gabriel
    Michallet, Mauricette
    Corront, Bernadette
    Lenain, Pascal
    Hulin, Cyrille
    Mathiot, Claire
    Attal, Michel
    Facon, Thierry
    Harousseau, Jean-Luc
    Minvielle, Stephane
    Moreau, Philippe
    BLOOD, 2011, 117 (06) : 2009 - 2011
  • [25] Prognostic significance of FSCN family in multiple myeloma
    Deng, Cong
    Si, Chaozeng
    Ye, Xu
    Zhou, Qiang
    Zeng, Tiansheng
    Huang, Zeyong
    Huang, Wenhui
    Zhu, Pei
    Zhong, Qingfu
    Wu, Zhihua
    Zhu, Huoyan
    Lin, Qing
    Zhang, Wenjuan
    Fu, Lin
    Zheng, Yongjiang
    Qian, Tingting
    JOURNAL OF CANCER, 2021, 12 (07): : 1936 - 1944
  • [26] Prognostic significance of chromosome aberrations in multiple myeloma
    Zubasheva, Ye. I.
    Obukhova, T. N.
    Andreyeva, N. Ye.
    Vodinskaya, L. A.
    Alimova, G. A.
    Varlamova, Ye. Yu.
    Kulikov, S. M.
    Domracheva, Ye. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (06): : 31 - 36
  • [27] Impact of Novel Agents on Young Patients with t(11;14) Multiple Myeloma
    Paludo, Jonas
    Vallumsetla, Nishanth
    Kumar, Shaji
    Ketterling, Rhett
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Buadi, Francis K.
    Dingli, David
    Painuly, Utkarsh
    Leung, Nelson
    Kyle, Robert
    Rajkumar, S. Vincent
    Kapoor, Prashant
    BLOOD, 2014, 124 (21)
  • [28] Dutcher bodies and Russell bodies in a case of t(11;14) multiple myeloma
    Wu, Jing
    Cai, Wei
    Jiang, Mi
    BRITISH JOURNAL OF HAEMATOLOGY, 2025, 206 (03) : 810 - 811
  • [29] Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma
    Bal, Susan
    Giri, Smith
    Godby, Kelly N.
    Costa, Luciano J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (01) : 112 - E116
  • [30] Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study
    Kumar, Shaji K.
    Lu, Jin
    Liu, Yang Terry
    Bittrich, Max
    Du, Juan
    Goldschmidt, Hartmut
    Kyriakou, Charalampia
    Reece, Donna E.
    Kim, Kihyun
    Mateos, Maria-Victoria
    De La Calle, Veronica Gonzalez
    Chen, Wenming
    Ludwig, Heinz
    Merlini, Giampaolo
    Mangiacavalli, Silvia
    Dimopoulos, Meletios A.
    Kastritis, Eftathios
    Min, Chang-Ki
    Esteves, Graca
    Yee, Andrew J.
    Raje, Noopur S.
    Rosta, Emily
    Haltner, Anja
    Cameron, Chris
    Durie, Brian G. M.
    BLOOD, 2019, 134
12345